Data presented as Developing Topics poster at AAIC 2026 - LEXINGTON, Mass., July 13, 2026 (GLOBE NEWSWIRE) -- Voyager ...

Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and delivery vectors. Molecular ...

Preconditioning-free (PC-free) 6-to-9-month clinical data with a single infusion of the lowest dose of rese-cel in the RESET-PV ® study presented today at ASGCT 2026 Annual Meeting along with initial ...

Mirai Bio, the innovation delivery partner for companies developing next generation nucleic acid medicines, today announced new preclinical data from an oral presentation at the American Society of ...

ASGCT–OTXL joint venture platform goes live with demo at ASGCT 2026 Annual Meeting and applications opening this month for qualified Asset listings The platform is being demonstrated live during the ...

Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine, this RNA fragment without free ends ...

Serif Biomedicines, a Flagship Pioneering company pioneering Modified DNA as a new class of medicines, today announced preclinical data supporting the potential of its platform to overcome key ...

Detailed price information for Lexeo Therapeutics Inc (LXEO-Q) from The Globe and Mail including charting and trades.

Some scientists build tools. Others build bridges. Mohamed Abou‑el‑Enein, MD, PhD, does both—engineering a high‑dimensional platform that temporally maps CAR T cells, while constructing the ...

Sensorion is a pioneering clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders, a significant global unmet ...

This presentation marks a critical step toward what KROMATID is building as the world's first genomic intelligence platform - a new category that moves beyond fragmented assays to deliver integrated, ...

Hans-Peter Kiem, MD, PhD, who holds the Stephanus Family Endowed Chair for Cell and Gene Therapy, has been awarded the 2026 George Stamatoyannopoulos Mentorship Award by the American Society of Gene ...